Question | Discussion | References | CME Credit

Case 2: Antiretroviral Regimens

You answered:

C Abacavir-lamivudine (Epzicom) plus raltegravir (Isentress)

This answer is incorrect. The use of abacavir-lamivudine in combination with raltegravir is considered an alternative regimen, not a preferred regimen.

A Zidovudine-lamivudine (Combivir) plus efavirenz (Sustiva)
B Tenofovir-emtricitabine (Truvada) plus ritonavir (Norvir) plus darunavir (Prezista)
D Tenofovir-emtricitabine (Truvada) plus lopinavir-ritonavir (Kaletra)

[Back to Case 2 Question | Go to Correct Answer]